"He’s implying that the because phase II trial had relatively few participants, it’s only really a Phase I."
wow, that's a truly idiotic misinterpretation of what I said.
// if they pass futility in a few weeks and the trial runs to the end as is designed and the endpoints are successful, agree it can satisfy NDA.
// If by accelerated approval you mean getting an approval before the end of the full trial based on just proteinuria result, then I reckon chances of that are slim to zero. it's very likely this trial will need to continue for the full 2 year follow up in all roughly 300 patients to get acceptable eGFR results, that's a few years away. if company had provided a recruitment update/forecast in the 4c as they really should have done imo, investors and analysts would have better idea of progress and likely trial completion time.
// and if they don't pass futility in a few weeks and trial folds, hard to see what the future is for this biotech as there is nothing else in their pipeline as far as I can see and this particular dmx2000 asset has no plausible alternative disease to pursue that I can see.
you can call this "trolling" , I really don't give a flying f##k, but this is how I see the situation , and so do others I've consulted on this.
- Forums
- ASX - By Stock
- Ann: Quarterly Appendix 4C and Activities Report
"He’s implying that the because phase II trial had relatively...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $280.6M |
Open | High | Low | Value | Volume |
51.5¢ | 54.5¢ | 51.0¢ | $1.715M | 3.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 365433 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 19658 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 348488 | 0.510 |
7 | 159577 | 0.505 |
9 | 326933 | 0.500 |
6 | 141020 | 0.495 |
8 | 79503 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 4807 | 1 |
0.535 | 6099 | 1 |
0.540 | 230559 | 3 |
0.545 | 8075 | 2 |
0.550 | 19750 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online